Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine versus midazolam for pediatric CT scan sedation
IRCT20190509043538N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine and midazolam in traumatic brain injury (TBI) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: onset of sedation, imaging time and 6 more. Started Jan 2018; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20190509043538N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190509043538N1.